Effects of amphetamine isomers and CNS catecholaminergic blockers on seizures in mice.
D000661:Amphetamine / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D002395:Catecholamines / Q000037:antagonists & inhibitors*; D003913:Dextroamphetamine / Q000494:pharmacology; D003984:Dibenzazepines / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004983:Ethanolamines / Q000494:pharmacology; D006220:Haloperidol / Q000494:pharmacology; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D010433:Pentylenetetrazole / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D010868:Pimozide / Q000494:pharmacology; D012640:Seizures / Q000139:chemically induced / Q000503:physiopathology*; D013015:Sotalol / Q000494:pharmacology; D013237:Stereoisomerism; D013997:Time Factors
D002395:Catecholamines; D003984:Dibenzazepines; D004983:Ethanolamines; D010868:Pimozide; D013015:Sotalol; D000661:Amphetamine; D006220:Haloperidol; D003913:Dextroamphetamine; D010433:Pentylenetetrazole; D010646:Phentolamine